Eversource Energy (D/B/A) Common Stock vs Personalis Inc. Common Stock — how do they compare? Eversource Energy (D/B/A) Common Stock trades at $67.1 (market cap $25.11B), while Personalis Inc. Common Stock trades at $15.92 (market cap $1.70B). The key difference: Eversource Energy (D/B/A) Common Stock is far larger — about 14.8× Personalis Inc. Common Stock's market cap, and Eversource Energy (D/B/A) Common Stock pays a 4.72% dividend while Personalis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Eversource Energy (D/B/A) Common Stock for 0 Days and Personalis Inc. Common Stock for 0 Days on average.
| ES | PSNL | |
|---|---|---|
Market Cap | $25.11B | $1.70B |
Volume | 3,164,400 | 3,262,398 |
Sector | Utilities | Health |
52-Week High | $76.21 | $18.38 |
52-Week Low | $63.28 | $5.04 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $55.18B | $1.52B |
Dividend Yield | 4.72% | — |
Signals from Pluang's Aura AI — not financial advice
Eversource Energy (ES) trades at $65.75, down 0.53% with neutral technical signals. The company maintains solid fundamentals with a 17.08 P/E ratio, 84.95% gross margin, and recent earnings beats in Q4 2025 and Q1 2026. Analyst consensus targets $73.75 with 31% buy ratings, while the company progresses on grid modernization projects and regulatory clarity in Connecticut.
ES offers steady utility exposure with 4.5% dividend yield and $26.5B capex plan supporting growth, though Q2 2026 earnings miss and regulatory uncertainty pose near-term risks. The stock presents value for income investors seeking regulated utility stability with infrastructure upside potential.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Eversource Energy is a regulated utility holding company delivering electricity, natural gas, and water to customers in Connecticut, Massachusetts, and New Hampshire. It operates through electric distribution and transmission, natural gas distribution, and water distribution segments, via subsidiaries including CL&P, NSTAR, PSNH, Yankee Gas, and Aquarion.
Read more on ES →Personalis Inc. is a cancer genomics company that provides tumor- and blood-based DNA and RNA sequencing tests, including its NeXT Personal liquid biopsy test for cancer monitoring.
Read more on PSNL →